Development of Macular Atrophy after Pars Plana Vitrectomy for Myopic Traction Maculopathy and Macular Hole Retinal Detachment in Pathologic Myopia

Written by: Musa Abdelaziz, MD October 2021 Fang, Y et al. “Development of macular atrophy after pars plana vitrectomy for myopic traction maculopathy and macular hole retinal detachment in pathologic myopia.” Retina. 2020 Oct;40(10):1881-1893. DOI: 10.1097/IAE.0000000000002709. Pathologic myopia (PM) is a major cause of legal blindness worldwide. The most serious lesion associated with severe vision […]

End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Written by: Philip P. Storey, MD October 2021 Khanani A, Callanan D, Dreyer R, Chen S, Howard J, Hopkins J, Lin C, Lorenz-Candlin M, Makadia S, Patel S, Tam T, Gune S. End-of-Study Results for the Ladder Phase 2 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmology Retina 2021;5:775-787. […]

Epiretinal Membrane Surgery after Retinal Detachment Repair: Visual Acuity Outcomes and OCT Analysis

Written by: Daniel Su, MD October 2021 Soares RR, Mahmoudzadeh R, Salabati M, Massenzio E, Israilevich R, Patel SN, Hinkle J, Kuriyan AE, Hsu J, Garg SJ, Khan MA. Epiretinal Membrane Surgery after Retinal Detachment Repair: Visual Acuity Outcomes and OCT Analysis. Ophthalmol Retina. 2021 Mar 29:S2468-6530(21)00103-2. Epiretinal membrane (ERM) formation commonly occurs after primary […]

Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery

Written by: Edward H. Wood, MD September 2021 Lee Dong Hyun, Sung Eun Park, and Christopher Seungkyu Lee. 2020. “Microcystic Macular Edema and Cystoid Macular Edema Before and After Epiretinal Membrane Surgery.” Retina Publish Ahead of Print (December). https://doi.org/10.1097/IAE.0000000000003087. This study is clinically useful by expanding our understanding of imaging biomarkers of idiopathic epiretinal membranes (ERM) […]

Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema

Written by: Mohsin H. Ali, MD September 2021 Gallardo, Mathias, et al. “Machine Learning Can Predict Anti–VEGF Treatment Demand in a Treat-and-Extend Regimen for Patients with Neovascular AMD, DME, and RVO Associated Macular Edema.” Ophthalmology Retina, vol. 5, no. 7, 2021, pp. 604–624., doi:10.1016/j.oret.2021.05.002.  Machine learning artificial intelligence models have the potential to improve our […]

Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration

Written by: Akshay S. Thomas, MD August 2021 Khurana RN, Kunimoto D, Yoon YH, et al. Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration. Ophthalmology. 2021;128(7):1027-1038.   Treatment options for wet AMD in 2019 included off-label use of bevacizumab or use of an FDA-approved agent, ranibizumab or […]

Long-term anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: the LATAR study. Report 1: ten-year, real-world outcomes.

Written by: Vlad Matei, MD August 2021 Spooner K, Fraser-Bell S, Hong T, et al. Long-term anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: the LATAR study. Report 1: ten-year, real-world outcomes. Ophthalmology Retina 2021;5(6):511-518. Neovascular age-related macular degeneration (nAMD) is one of the most common and debilitating diseases encountered by retinal specialists. […]

Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH

Written by: Joshua D. Levinson, MD August 2021 Chan CK, Mein CE, Glassman AR, et al. Pneumatic Vitreolysis with C3F8 for Vitreomacular Traction with and without Macular Hole: DRCR Retina Network Protocols AG and AH. Ophthalmol. 2021 Treatment options for symptomatic vitreomacular traction (VMT) and macular hole (MH) include observation, pars plana vitrectomy and vitreolysis. […]